Login / Signup

Comment on 'Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study'.

Chandler E JohnsonPayton SmithKathryn HaranAllison KranyakWilson LiaoTina Bhutani
Published in: The British journal of dermatology (2024)
Keyphrases
  • placebo controlled
  • atopic dermatitis
  • double blind
  • phase iii
  • phase ii
  • study protocol
  • phase ii study
  • clinical trial
  • physical activity
  • sleep quality
  • squamous cell carcinoma
  • open label